| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | 2.04e-05 | 4 | 35 | 2 | 1.10.150.220 | |
| Domain | PP1_inhibitor | 2.04e-05 | 4 | 35 | 2 | IPR008025 | |
| Domain | PP1_inhibitor | 2.04e-05 | 4 | 35 | 2 | PF05361 | |
| Pubmed | Cell-based receptor discovery identifies host factors specifically targeted by the SARS CoV-2 spike. | 9.82e-06 | 5 | 35 | 2 | 35931765 | |
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 29434374 | ||
| Pubmed | A cellular and spatial map of the choroid plexus across brain ventricles and ages. | 2.92e-05 | 59 | 35 | 3 | 33932339 | |
| Pubmed | 7.34e-05 | 1440 | 35 | 8 | 30833792 | ||
| Pubmed | Chromosome mapping of the mouse Akt2 gene and Akt2 pseudogene. | 7.62e-05 | 13 | 35 | 2 | 8976376 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 1.30e-04 | 1155 | 35 | 7 | 20360068 | |
| Pubmed | Role of Ostm1 Cytosolic Complex with Kinesin 5B in Intracellular Dispersion and Trafficking. | 1.49e-04 | 18 | 35 | 2 | 26598607 | |
| Pubmed | 1.87e-04 | 110 | 35 | 3 | 25940091 | ||
| Pubmed | Proteostatic control of telomerase function through TRiC-mediated folding of TCAB1. | 2.04e-04 | 21 | 35 | 2 | 25467444 | |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 2.36e-04 | 119 | 35 | 3 | 35776542 | |
| Pubmed | Genomic evolution of the placenta using co-option and duplication and divergence. | 3.15e-04 | 26 | 35 | 2 | 18340042 | |
| Pubmed | The basement membrane of hair follicle stem cells is a muscle cell niche. | 3.66e-04 | 28 | 35 | 2 | 21335239 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 5.31e-04 | 1455 | 35 | 7 | 22863883 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 5.39e-04 | 1038 | 35 | 6 | 26673895 | |
| Pubmed | 7.49e-04 | 40 | 35 | 2 | 18051367 | ||
| Pubmed | Characterization of LGALS3 (galectin-3) as a player in DNA damage response. | 9.90e-04 | 46 | 35 | 2 | 24755837 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q12 | 1.07e-03 | 63 | 35 | 2 | chr12q12 | |
| GeneFamily | Immunoglobulin like domain containing | 1.19e-03 | 193 | 20 | 3 | 594 | |
| GeneFamily | Fibronectin type III domain containing | 1.33e-02 | 160 | 20 | 2 | 555 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.68e-02 | 181 | 20 | 2 | 694 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14 | 3.90e-05 | 143 | 35 | 4 | M8751 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14 | 4.23e-05 | 146 | 35 | 4 | MM1283 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_DN | 6.20e-05 | 9 | 35 | 2 | MM1242 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_DN | 6.20e-05 | 9 | 35 | 2 | M18073 | |
| ToppCell | (03)_Secretory-(3)_72hpi|(03)_Secretory / shred by cell type and Timepoint | 7.04e-06 | 158 | 35 | 4 | 20563d03183b63aafc9c389f3f03781140702249 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.20e-05 | 181 | 35 | 4 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 188 | 35 | 4 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 188 | 35 | 4 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.40e-05 | 188 | 35 | 4 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 1.43e-05 | 189 | 35 | 4 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.52e-05 | 192 | 35 | 4 | 450baeb5c3df7a9445472530002ce38f177a333c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.55e-05 | 193 | 35 | 4 | efa91167dc7a59bf32addf90ffb7bf070b2a0151 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.75e-05 | 199 | 35 | 4 | 6748d4f76703360071d5f2026d9d06bf30ccfb6d | |
| ToppCell | TCGA-Lung-Primary_Tumor|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.75e-05 | 199 | 35 | 4 | d1d035e987280607266171094db5d6362efe1ad5 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.75e-05 | 199 | 35 | 4 | 6f159c1215439ec22374903124085746fa8da333 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.85e-06 | 50 | 22 | 4 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_MYC_MITOCHONDRIA | |
| Computational | Neighborhood of XRCC5 | 4.57e-04 | 75 | 22 | 3 | GNF2_XRCC5 | |
| Computational | Neighborhood of UNG | 4.75e-04 | 76 | 22 | 3 | MORF_UNG | |
| Disease | response to bevacizumab, chemotherapy-induced hypertension | 3.64e-06 | 3 | 33 | 2 | EFO_0005942, EFO_0005943 | |
| Disease | contactin-1 measurement | 1.81e-05 | 6 | 33 | 2 | EFO_0020286 | |
| Disease | 2-hydroxystearate measurement | 4.35e-05 | 9 | 33 | 2 | EFO_0021059 | |
| Disease | cumulative dose response to bevacizumab | 2.05e-04 | 19 | 33 | 2 | EFO_0005944 | |
| Disease | HIV Coinfection | 2.09e-04 | 103 | 33 | 3 | C4505456 | |
| Disease | HIV Infections | 2.09e-04 | 103 | 33 | 3 | C0019693 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 1.38e-03 | 49 | 33 | 2 | EFO_0006954, EFO_1001069 | |
| Disease | Major Depressive Disorder | 2.51e-03 | 243 | 33 | 3 | C1269683 | |
| Disease | Unipolar Depression | 3.00e-03 | 259 | 33 | 3 | C0041696 | |
| Disease | cerebral amyloid deposition measurement | 5.07e-03 | 95 | 33 | 2 | EFO_0007707 | |
| Disease | Parkinson disease | 5.47e-03 | 321 | 33 | 3 | MONDO_0005180 | |
| Disease | reaction time measurement | 6.00e-03 | 658 | 33 | 4 | EFO_0008393 | |
| Disease | platelet-to-lymphocyte ratio | 7.67e-03 | 363 | 33 | 3 | EFO_0008446 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RIECYEVNYQPLDEE | 196 | P16118 | |
| EDETICQINEEPGYV | 171 | P35348 | |
| IDPIRQEDAGEYQCE | 201 | Q3KPI0 | |
| KENECLGDYPEVLQE | 171 | P49238 | |
| DIEQEVNCLSPEYDA | 141 | Q01459 | |
| GYCEEIPVEENEVND | 246 | Q3KR37 | |
| VNIPAAECLDEYEDD | 166 | Q96IZ0 | |
| PTCQEDEEDVRYNIV | 386 | Q9NP74 | |
| EVLEEISCYPENNDA | 411 | O14936 | |
| DQENCVYETVVLPLD | 146 | Q53EL6 | |
| EENYELRDIVLDCPD | 8341 | Q7Z5P9 | |
| DDYEVSCPELDQLVE | 316 | P51570 | |
| EVEEEQEDPYLNDRC | 166 | P23142 | |
| EVEEDYNPCEEDLFV | 376 | A4D1U4 | |
| YCMEEPQDDQEVNEL | 3741 | Q8N3K9 | |
| QLEDEGIYECEAENI | 301 | Q12860 | |
| LEAIGYICQDIDPEQ | 151 | Q14974 | |
| LQEPEEDEDCYILNV | 11 | Q96QF7 | |
| PEECDYLRQEVQENA | 551 | P57679 | |
| DQEYLCNIGDLELPE | 186 | Q92681 | |
| QEAYDECLEEVQSLP | 136 | Q9NX24 | |
| EEILAYQPDILCLQE | 181 | Q9UK39 | |
| IVEQLGQLYGCEEEE | 91 | Q8TAE6 | |
| EELPEDLYDENVCQP | 326 | P09001 | |
| EEELAQQYELIIQEC | 131 | Q496J9 | |
| CEELYPEELLIDHQT | 296 | O14545 | |
| LDCDNPEEEQFALEV | 416 | Q9NP60 | |
| DCDLLREQYEEEQEV | 1351 | Q9Y2K3 | |
| EEEYIQQLCEDIIQL | 271 | P49368 | |
| RLYDCQEEEIPELEI | 81 | Q96C90 | |
| EDEEVLTLLYDPCLN | 661 | Q6ZVT6 | |
| FCQEDLEEEENLPEE | 966 | Q9UNS1 | |
| EPDYQDCEDLEIIRN | 316 | Q9UH36 | |
| LYNVPDCLEDIQDAD | 106 | Q9Y2K1 | |
| NAEDCLYELPENIRV | 141 | Q9NZ63 |